Waldiomycin is an inhibitor of histidine kinases (HKs). Although most HK inhibitors target the ATP-binding region, waldiomycin binds to the intracellular dimerization domain (DHp domain) with its naphthoquinone moiety presumed to interact with the conserved H-box region. To further develop inhibitors targeting the H-box, various 2-aminonaphthoquinones with cyclic, aliphatic, or aromatic amino groups and naphtho [2,3-d] isoxazole-4,9-diones were synthesized. These compounds were tested for their inhibitory activity (IC50) against WalK, an essential HK for Bacillus subtilis growth, and their minimum inhibitory concentrations (MIC) against B. subtilis. As a result, 11 novel HK inhibitors were obtained as naphthoquinone derivatives (IC50: 12.6-305 µM, MIC: 0.5-128 µg ml-1). The effect of representative compounds on the expression of WalK/WalR regulated genes in B. subtilis was investigated. Four naphthoquinone derivatives induced the expression of iseA (formerly yoeB), whose expression is negatively regulated by the WalK/WalR system. This suggests that these compounds inhibit WalK in B. subtilis cells, resulting in antibacterial activity. Affinity selection/mass spectrometry analysis was performed to identify whether these naphthoquinone derivatives interact with WalK in a manner similar to waldiomycin. Three compounds were found to competitively inhibit the binding of waldiomycin to WalK, suggesting that they bind to the H-box region conserved in HKs and inhibit HK activity.

Synthesis and biochemical characterization of naphthoquinone derivatives targeting bacterial histidine kinases / Ishikawa, Teruhiko; Eguchi, Yoko; Igarashi, Masayuki; Okajima, Toshihide; Mita, Kohei; Yamasaki, Yuri; Sumikura, Kaho; Okumura, Taisei; Tabuchi, Yuna; Hayashi, Chigusa; Pasqua, Martina; Coluccia, Marco; Prosseda, Gianni; Colonna, Bianca; Kohayakawa, Chie; Tani, Akiyoshi; Haruta, Jun-ichi; Utsumi, Ryutaro. - In: JOURNAL OF ANTIBIOTICS. - ISSN 0021-8820. - (2024). [10.1038/s41429-024-00726-2]

Synthesis and biochemical characterization of naphthoquinone derivatives targeting bacterial histidine kinases

Pasqua, Martina;Coluccia, Marco;Prosseda, Gianni;Colonna, Bianca;
2024

Abstract

Waldiomycin is an inhibitor of histidine kinases (HKs). Although most HK inhibitors target the ATP-binding region, waldiomycin binds to the intracellular dimerization domain (DHp domain) with its naphthoquinone moiety presumed to interact with the conserved H-box region. To further develop inhibitors targeting the H-box, various 2-aminonaphthoquinones with cyclic, aliphatic, or aromatic amino groups and naphtho [2,3-d] isoxazole-4,9-diones were synthesized. These compounds were tested for their inhibitory activity (IC50) against WalK, an essential HK for Bacillus subtilis growth, and their minimum inhibitory concentrations (MIC) against B. subtilis. As a result, 11 novel HK inhibitors were obtained as naphthoquinone derivatives (IC50: 12.6-305 µM, MIC: 0.5-128 µg ml-1). The effect of representative compounds on the expression of WalK/WalR regulated genes in B. subtilis was investigated. Four naphthoquinone derivatives induced the expression of iseA (formerly yoeB), whose expression is negatively regulated by the WalK/WalR system. This suggests that these compounds inhibit WalK in B. subtilis cells, resulting in antibacterial activity. Affinity selection/mass spectrometry analysis was performed to identify whether these naphthoquinone derivatives interact with WalK in a manner similar to waldiomycin. Three compounds were found to competitively inhibit the binding of waldiomycin to WalK, suggesting that they bind to the H-box region conserved in HKs and inhibit HK activity.
2024
drug discovery; drug development; small molecules; two component system; histidine kinase
01 Pubblicazione su rivista::01a Articolo in rivista
Synthesis and biochemical characterization of naphthoquinone derivatives targeting bacterial histidine kinases / Ishikawa, Teruhiko; Eguchi, Yoko; Igarashi, Masayuki; Okajima, Toshihide; Mita, Kohei; Yamasaki, Yuri; Sumikura, Kaho; Okumura, Taisei; Tabuchi, Yuna; Hayashi, Chigusa; Pasqua, Martina; Coluccia, Marco; Prosseda, Gianni; Colonna, Bianca; Kohayakawa, Chie; Tani, Akiyoshi; Haruta, Jun-ichi; Utsumi, Ryutaro. - In: JOURNAL OF ANTIBIOTICS. - ISSN 0021-8820. - (2024). [10.1038/s41429-024-00726-2]
File allegati a questo prodotto
File Dimensione Formato  
Ishikawa_Synthesis_2024.pdf

accesso aperto

Note: PDF file
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.61 MB
Formato Adobe PDF
1.61 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1714211
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact